Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,263 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,163
Recruiting: 2,261
Ph III recruiting: 268
Growth YoY: +12.8%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,897)

clinicaltrialsPublishedShowing 551–600 of 6,228 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07768436	A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer	recruiting	Phase 2	76	Memorial Sloan Kettering Cancer CenterOTHER	1	Aug 17, 2026	clinicaltrials
NCT03283605	Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas	completed	Phase 1 / Phase 2	33	Centre hospitalier de l'Université de Montréal (CHUM)OTHER	1	Aug 14, 2026	clinicaltrials